All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Intercept Pharmaceuticals Inc., of New York, said it priced its public offering of 2.4 million shares of common stock at $83.50 per share, for gross proceeds of about $200.4 million.
